|
US4617307A
(en)
|
1984-06-20 |
1986-10-14 |
Ciba-Geigy Corporation |
Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
|
|
US4889861A
(en)
|
1982-12-21 |
1989-12-26 |
Ciba-Geigy Corp. |
Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5114946A
(en)
|
1987-06-12 |
1992-05-19 |
American Cyanamid Company |
Transdermal delivery of pharmaceuticals
|
|
US4818541A
(en)
|
1987-08-19 |
1989-04-04 |
Schering Corporation |
Transdermal delivery of enantiomers of phenylpropanolamine
|
|
ES2113879T3
(es)
|
1990-01-24 |
1998-05-16 |
Douglas I Buckley |
Analogos de glp-1 utiles para el tratamiento de diabetes.
|
|
US5155100A
(en)
|
1991-05-01 |
1992-10-13 |
Ciba-Geigy Corporation |
Phosphono/biaryl substituted dipeptide derivatives
|
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
PE20020082A1
(es)
|
2000-04-12 |
2002-02-21 |
Novartis Ag |
Composicion farmaceutica que comprende un inhibidor de aldosterona-sintasa y un antagonista del receptor de angiotensina ii (at1)
|
|
TW200303742A
(en)
|
2001-11-21 |
2003-09-16 |
Novartis Ag |
Organic compounds
|
|
AU2003232941A1
(en)
|
2002-06-07 |
2003-12-22 |
Glaxo Group Limited |
N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them
|
|
ES2270143T3
(es)
|
2002-08-07 |
2007-04-01 |
Novartis Ag |
Compuestos organicos como agentes para el tratamiento de condiciones mediadas por aldosterona.
|
|
ES2305520T3
(es)
|
2002-11-18 |
2008-11-01 |
Novartis Ag |
Derivados de imidazo(1,5a)piridina y metodos para tratar enfermedades mediadas por aldosterona.
|
|
AR044399A1
(es)
|
2003-05-20 |
2005-09-14 |
Novartis Ag |
Compuestos heterociclicos y su uso como activadores de receptores de ppar. composiciones farmaceuticas que los contienen
|
|
AR049126A1
(es)
|
2004-05-28 |
2006-06-28 |
Speedel Experimenta Ag |
Derivados de 5, 6, 7, 8 - tetrahidroimidazo[1,5a]piridina con actividad inhibitoria de la aldosterona sintasa, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento del hiperaldosterismo y del sindrome de cushing.
|
|
US20080076794A1
(en)
|
2004-05-28 |
2008-03-27 |
Peter Herold |
Heterocyclic Compounds And Their Use As Aldosterone Synthase Inhibitors
|
|
US7612088B2
(en)
|
2004-05-28 |
2009-11-03 |
Speedel Experimenta Ag |
Heterocyclic compounds and their use as aldosterone synthase inhibitors
|
|
AR049711A1
(es)
|
2004-07-09 |
2006-08-30 |
Speedel Experimenta Ag |
Compuestos heterociclicos condensados como inhibidores de la aldosterona sintasa; composiciones farmaceuticas que los contienen y su uso en la preparacion de un medicamento para el tratamiento o prevencion de enfermedades relacionadas con el hiperaldosterismo y por una liberacion excesiva de cortiso
|
|
TW200716634A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
TW200716636A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
TW200716105A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Imidazole compounds
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
TW200804378A
(en)
|
2005-12-09 |
2008-01-16 |
Speedel Experimenta Ag |
Organic compounds
|
|
PT2402319T
(pt)
|
2006-03-31 |
2017-12-11 |
Novartis Ag |
Inibidores de dgat
|
|
CN101415803B
(zh)
|
2006-04-04 |
2012-10-24 |
大阳日酸株式会社 |
甲烷分离方法、甲烷分离装置以及甲烷利用系统
|
|
TW200808813A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
TW200808812A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
EP1886695A1
(en)
|
2006-06-27 |
2008-02-13 |
Speedel Experimenta AG |
Pharmaceutical combination of an aldosterone synthase inhibitor and a glucocorticoid receptor antagonist or a cortisol synthesis inhibitor or a corticotropin releasing factor antagonist
|
|
WO2008027284A1
(en)
|
2006-08-25 |
2008-03-06 |
Novartis Ag |
Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase
|
|
EA200900811A1
(ru)
|
2006-12-18 |
2009-12-30 |
Новартис Аг |
Имидазолы в качестве ингибиторов альдостеронсинтазы
|
|
WO2008076862A2
(en)
|
2006-12-18 |
2008-06-26 |
Novartis Ag |
1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
|
|
KR20090090395A
(ko)
|
2006-12-18 |
2009-08-25 |
노파르티스 아게 |
4-이미다졸릴-1,2,3,4-테트라히드로퀴놀린 유도체 및 알도스테론/11-베타-히드록실라제 억제제로서의 그의 용도
|
|
AR066691A1
(es)
|
2007-03-29 |
2009-09-09 |
Speedel Experimenta Ag |
Compuestos espiro heterociclicos derivados de imidazol. composiciones farmaceuticas.
|
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
|
JP2010538071A
(ja)
|
2007-09-07 |
2010-12-09 |
セラヴァンス, インコーポレーテッド |
二重作用性降圧剤
|
|
AR066169A1
(es)
|
2007-09-28 |
2009-07-29 |
Novartis Ag |
Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat
|
|
JP2011518884A
(ja)
|
2008-04-29 |
2011-06-30 |
セラヴァンス, インコーポレーテッド |
二重活性抗高血圧剤
|
|
AR072297A1
(es)
|
2008-06-27 |
2010-08-18 |
Novartis Ag |
Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
|
|
US9085527B2
(en)
*
|
2008-07-08 |
2015-07-21 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid acylated salicylates and their uses
|
|
AU2009305893B2
(en)
*
|
2008-10-23 |
2014-03-27 |
Steba Biotech S.A. |
RGD-containing peptidomimetics and uses thereof
|
|
ES2459468T3
(es)
|
2009-05-15 |
2014-05-09 |
Novartis Ag |
Arilpiridinas como inhibidores de aldosterona sintasa
|
|
PL2435409T3
(pl)
|
2009-05-28 |
2015-01-30 |
Novartis Ag |
Podstawione pochodne aminopropionowe jako inhibitory neprylizyny
|
|
CA2763565A1
(en)
|
2009-05-28 |
2010-12-02 |
Novartis Ag |
Substituted aminobutyric derivatives as neprilysin inhibitors
|
|
JO2967B1
(en)
|
2009-11-20 |
2016-03-15 |
نوفارتس ايه جي |
Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
|
|
US8673974B2
(en)
|
2010-11-16 |
2014-03-18 |
Novartis Ag |
Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
|
|
US8877815B2
(en)
|
2010-11-16 |
2014-11-04 |
Novartis Ag |
Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
|
|
SI2651896T1
(sl)
|
2010-12-15 |
2015-11-30 |
Theravance Biopharma R&D Ip, Llc |
Inhibitorji neprilizina
|
|
AU2012217615B2
(en)
|
2011-02-17 |
2016-09-29 |
Theravance Biopharma R&D Ip, Llc |
Substituted aminobutyric derivatives as neprilysin inhibitors
|
|
CA2835281A1
(en)
|
2011-05-31 |
2012-12-06 |
Theravance, Inc. |
Neprilysin inhibitors
|
|
ES2653215T3
(es)
|
2011-05-31 |
2018-02-06 |
Theravance Biopharma R&D Ip, Llc |
Inhibidores de neprilisina
|
|
TWI560172B
(en)
|
2011-11-02 |
2016-12-01 |
Theravance Biopharma R&D Ip Llc |
Neprilysin inhibitors
|
|
LT2864292T
(lt)
|
2012-06-08 |
2017-07-10 |
Theravance Biopharma R&D Ip, Llc |
Neprilizino inhibitoriai
|
|
DE102012014480A1
(de)
|
2012-07-21 |
2014-01-23 |
Daimler Ag |
Aufbau eines Innendekors
|
|
US9126956B2
(en)
|
2012-08-08 |
2015-09-08 |
Theravance Biopharma R&D Ip, Llc |
Neprilysin inhibitors
|
|
SG11201506018PA
(en)
|
2013-02-14 |
2015-08-28 |
Novartis Ag |
Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
|
|
HUE034210T2
(hu)
|
2013-03-05 |
2018-02-28 |
Theravance Biopharma R&D Ip Llc |
Neprilizininhibitorok
|
|
EP2968318A4
(en)
*
|
2013-03-15 |
2016-12-14 |
Shifa Biomedical Corp |
ANTI-PCSK9 COMPOUNDS AND METHODS FOR TREATING AND / OR PREVENTING CARDIOVASCULAR DISEASES
|
|
MX2016009760A
(es)
|
2014-01-30 |
2016-11-08 |
Theravance Biopharma R&D Ip Llc |
Inhibidores de neprilisina.
|
|
EP3099668B1
(en)
|
2014-01-30 |
2022-05-04 |
Theravance Biopharma R&D IP, LLC |
5-biphenyl-4-heteroarylcarbonylamino-pentanoic acid derivatives as neprilysin inhibitors
|